Your browser doesn't support javascript.
loading
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
Hou, Zhi-Jie; Luo, Xi; Zhang, Wei; Peng, Fei; Cui, Bai; Wu, Si-Jin; Zheng, Fei-Meng; Xu, Jie; Xu, Ling-Zhi; Long, Zi-Jie; Wang, Xue-Ting; Li, Guo-Hui; Wan, Xian-Yao; Yang, Yong-Liang; Liu, Quentin.
Afiliação
  • Hou ZJ; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Luo X; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhang W; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Peng F; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Cui B; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wu SJ; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Zheng FM; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Xu J; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Xu LZ; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Long ZJ; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wang XT; Center for Molecular Medicine, School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China.
  • Li GH; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Wan XY; Department of Hematology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Yang YL; Department of Critical Care Medicine, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • Liu Q; Center for Molecular Medicine, School of Life Science and Biotechnology, Dalian University of Technology, Dalian, China.
Oncotarget ; 6(8): 6326-40, 2015 Mar 20.
Article em En | MEDLINE | ID: mdl-25811972

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias da Mama / Mebendazol Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Neoplasias da Mama / Mebendazol Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article